title: Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study.
abstract: OBJECTIVE
  To evaluate the efficacy of a programme of home blood pressure measurement (HBPM) on therapeutic compliance in mild-to-moderate hypertension.
  
  
  METHODS
  A prospective controlled multicentre clinical trial.
  
  
  METHODS
  Forty primary care centres in Spain, with a duration of 6 months.
  
  
  METHODS
  A total of 250 patients with newly diagnosed or uncontrolled hypertension were included.
  
  
  METHODS
  The patients were randomly selected and distributed in two groups: (1) the control group (CG) who received standard health intervention; (2) the intervention group (IG): the patients in this group received an OMRON in their homes for a programme of HBPM.
  
  
  METHODS
  Four visits were scheduled, for the measurement of blood pressure (BP). They were provided with an electronic monitor for measuring compliance (monitoring events medication system; MEMS). Therapeutic compliance was defined as a drug consumption of 80-110%. A number of variables were calculated using the MEMS. The mean BP were calculated and the percentage of controlled patients.
  
  
  RESULTS
  A total of 200 patients completed the study (100 in each group). Compliance was observed in 74 and 92%, respectively, in the CG and IG [95% confidence interval (CI) 63.9-84.1 and 86.7-97.3; P = 0.0001], the mean percentage compliances were 87.6 and 93.5% (95% CI 81.2-94 and 80.7-98.3; P = 0.0001), the percentages of correct days were 83.6 and 89.4%, the percentages of subjects who took the medication at the prescribed time were 79.89 and 88.06%, and the levels of therapeutic cover were 86.7 and 93.1%. The number needed to treat to avoid one case of non-compliance was 5.6 patients. The differences in the mean decreases in BP were significant for diastolic BP, with a greater decrease observed in the IG.
  
  
  CONCLUSIONS
  An HBPM programme using electronic monitors is effective in improving compliance in arterial hypertension, measured using the MEMS.
authors.affiliation: La Orden Health Centre, Huelva, Spain. emarquezc@papps.org
authors.forename: Emilio
authors.initials: E
authors.lastname: Márquez-Contreras
authors.forename: Nieves
authors.initials: N
authors.lastname: Martell-Claros
authors.forename: Vicente
authors.initials: V
authors.lastname: Gil-Guillén
authors.forename: Mariano
authors.initials: M
authors.lastname: de la Figuera-Von Wichmann
authors.forename: José Joaquín
authors.initials: JJ
authors.lastname: Casado-Martínez
authors.forename: José Luis
authors.initials: JL
authors.lastname: Martin-de Pablos
authors.forename: Montse
authors.initials: M
authors.lastname: Figueras
authors.forename: Jordi
authors.initials: J
authors.lastname: Galera
authors.forename: Alicia
authors.initials: A
authors.lastname: Serra
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D018660:Blood Pressure Monitoring, Ambulatory; D015924:Blood Pressure Monitors; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011446:Prospective Studies
chemical_list: D000959:Antihypertensive Agents